Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
8-(pyrimidin-2-ylamino)naphthalene-2-carboximidamide is a synthetic small molecule compound classified as a carboxamidine, naphthalene derivative, and aminopyrimidine. It has the molecular formula C15H13N5 and a molecular weight of approximately 263.3 g/mol[4][5][10]. The compound is primarily of interest in medicinal chemistry research, with no current approved medical indications or clinical use. Its mechanism of action and biological targets are not well characterized in public databases, but it has been studied as an experimental ligand in protein structure studies[4]. There are no known approved products or marketed formulations containing this compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 8-(pyrimidin-2-ylamino)naphthalene-2-carboximidamide.